Author: digi

Managing Shared Equipment and Instruments in a DI-Compliant Way: A Step-by-Step GMP Tutorial Managing Shared Equipment and Instruments in a Data Integrity-Compliant Way Pharmaceutical manufacturing environments operating within the US, UK, and EU must ensure robust data integrity while managing shared equipment and instruments. Compliance with regulatory frameworks such as 21 CFR Part 11 in…

Read More “Managing Shared Equipment and Instruments in a DI-Compliant Way” »

Managing Shared Equipment and Instruments in a DI-Compliant Way Step-by-Step Guide to Managing Shared Equipment and Instruments with Data Integrity Compliance In pharmaceutical manufacturing environments within the US, UK, and EU, managing shared equipment and instruments in a manner compliant with data integrity (DI) principles is imperative. Regulatory bodies including the FDA, EMA, MHRA, PIC/S,…

Read More “Managing Shared Equipment and Instruments in a DI-Compliant Way” »

Data Integrity in Electronic Temperature and Humidity Monitoring Systems Ensuring Data Integrity in Electronic Temperature and Humidity Monitoring Systems: A Step-by-Step Tutorial In pharmaceutical manufacturing and clinical operations, environmental monitoring forms an essential part of Good Manufacturing Practice (GMP). Particularly, the electronic monitoring of temperature and humidity is critical for maintaining product quality and patient…

Read More “Data Integrity in Electronic Temperature and Humidity Monitoring Systems” »

Data Integrity in Electronic Temperature and Humidity Monitoring Systems Ensuring Data Integrity in Electronic Temperature and Humidity Monitoring Systems: A Step-by-Step GMP Tutorial Guide Electronic temperature and humidity monitoring systems are critical components of pharmaceutical Good Manufacturing Practice (GMP) environments. These systems help maintain product quality by ensuring storage and manufacturing environments stay within defined…

Read More “Data Integrity in Electronic Temperature and Humidity Monitoring Systems” »

Designing a DI-Aware Change Control Template for GxP Systems Step-by-Step Guide to Designing a Data Integrity-Aware Change Control Template for GxP Systems In the pharmaceutical industry, ensuring data integrity throughout manufacturing, clinical, and regulatory processes is paramount to patient safety and regulatory compliance. With global regulatory agencies emphasizing strict adherence to principles such as ALCOA+…

Read More “Designing a DI-Aware Change Control Template for GxP Systems” »

Designing a DI-Aware Change Control Template for GxP Systems Step-by-Step Guide to Designing a Data Integrity-Aware Change Control Template for GxP Systems Managing change control within Good Manufacturing Practice (GMP) regulated environments requires a comprehensive approach that aligns with data integrity (DI) principles and regulatory requirements such as 21 CFR Part 11 and Annex 11….

Read More “Designing a DI-Aware Change Control Template for GxP Systems” »

Ensuring DI in GMP Training Systems and E-Learning Platforms Practical Guide to Ensuring Data Integrity in GMP Training Systems and E-Learning Platforms The pharmaceutical industry is held to the highest standards regarding data management, with robust compliance expectations for data integrity embedded in various regulations including 21 CFR Part 11, Annex 11 of the EU…

Read More “Ensuring DI in GMP Training Systems and E-Learning Platforms” »

Ensuring DI in GMP Training Systems and E-Learning Platforms Ensuring Data Integrity in GMP Training Systems and E-Learning Platforms: A Step-by-Step Tutorial Guide In the context of pharmaceutical manufacturing and compliance, data integrity (DI) is paramount across all GxP systems, including GMP training systems and e-learning platforms. The accuracy, reliability, and security of training records…

Read More “Ensuring DI in GMP Training Systems and E-Learning Platforms” »

Managing DI in Deviations, CAPA, Complaints and Change Control Systems Comprehensive Step-by-Step Guide to Managing Data Integrity in Deviations, CAPA, Complaints, and Change Control Systems Effective management of data integrity within pharmaceutical Quality Management Systems (QMS) is essential to ensure product quality, patient safety, and regulatory compliance. This is especially critical in the context of…

Read More “Managing DI in Deviations, CAPA, Complaints and Change Control Systems” »

Reconstructing Historical Studies When Legacy Data Integrity Issues Are Found Step-by-Step Tutorial for Reconstructing Historical Studies Amid Legacy Data Integrity Issues Pharmaceutical manufacturers and clinical research organizations face significant challenges when discovering data integrity issues in legacy studies. Such historic studies may underpin regulatory submissions, product approvals, or postmarket surveillance activities. Correctly addressing data integrity…

Read More “Reconstructing Historical Studies When Legacy Data Integrity Issues Are Found” »